Effects of p-chloromercuribenzene sulfonate on the uptake of D- and L-leucines in Ehrlich ascites tumor cells.

In order to ascertain the significance of the hydrophobic region in the carrier protein responsible for the D-leucine transport reported previously, the effects of p-chloromercuribenzene sulfonate (PCMBS) were investigated on the transport of D- and L-leucines in Ehrlich ascites tumor cells. The uptake of D-leucine in the presence of PCMBS was inhibited more strongly than that of L-leucine. Km values for D-leucine uptake increased with increasing concentration of PCMBS, while those for L-leucine showed only a little increase. D-Leucine uptake was restored considerably from the PCMBS inhibition by washing with buffer, whereas L-leucine uptake was only slightly affected. The inhibition of D-leucine exit by PCMBS was also higher than that of L-leucine. These results suggest that the binding site of PCMBS for the carrier protein of Ehrlich cells is involved in its hydrophobic region that would be more significant for the binding of alkyl side chain D-leucine than that of L-leucine.
AuthorsR Goto, S Hanamura, O Tamemasa
JournalJournal of pharmacobio-dynamics (J Pharmacobiodyn) Vol. 5 Issue 10 Pg. 780-8 (Oct 1982) ISSN: 0386-846X [Print] JAPAN
PMID6298399 (Publication Type: Journal Article)
Chemical References
  • Phenylmercury Compounds
  • 4-Chloromercuribenzenesulfonate
  • Sodium
  • Leucine
  • 4-Chloromercuribenzenesulfonate (metabolism, pharmacology)
  • Animals
  • Binding Sites
  • Carcinoma, Ehrlich Tumor (metabolism)
  • Cells, Cultured
  • Diffusion
  • Kinetics
  • Leucine (metabolism)
  • Mice
  • Phenylmercury Compounds (pharmacology)
  • Sodium (pharmacology)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: